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Abstract
Congenital abnormalities of the kidney and urinary tract collectively form the most common
type of prenatally diagnosed malformations. Whilst many of the crucial genes that direct the
kidney developmental program are known, the mechanisms by which kidney organogenesis
is achieved is still largely unclear. In this paper, we propose a mathematical model for the
localisation of the ureteric bud, the precursor to the ureter and collecting duct system of
the kidney. The mathematical model presented fundamentally implicates Schnakenberg-like
ligand-receptor Turing patterning as the mechanism by which the ureteric bud is localised
on the Wolfian duct as proposed in 2013 by Menshykaul and Iber [19]. This model explores
the specific roles of regulatory proteins GREM1 and BMP as well as the domain proper-
ties of GDNF production. Our model demonstrates that this proposed pattern formation
mechanism is capable of naturally predicting the phenotypical outcomes of many genetic
experiments from the literature. Furthermore, we conclude that whilst BMP inhibits GDNF
away from the budding site and GREM1 permits GDNF to signal, GREM1 also stabilises
the effect of BMP on GDNF signalling from fluctuations in BMP sensitivity but not signal
strength.
Keywords:
Turing patterning, Kidney morphogenesis, Partial differential equations, Developmental
biology, Mathematical biology
1. Introduction
Congenital abnormalities of the kidney and urinary tract, collectively known as CAKUT,
represent approximately one third of all prenatally diagnosed malformations [22]. Abnor-
malities associated with the kidneys are a major cause of chronic kidney disease in children
and young adults, often requiring transplantation or dialysis [27]. Furthermore, less severe
congenital abnormalities of the kidney can have life-long implications including hypertension
and/or proteinuria [27]. In approximately one in 4000 births, CAKUT can result in bilateral
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renal agenesis (also known as classic Potter’s syndrome: the absence of any kidney or ureter
phenotype) and is typically fatal within the first few hours after birth [24].
Despite the severity and frequency associated with disruptions in kidney development,
the full picture of metanephros (kidney) organogenesis is still poorly understood. For the
current state of scientific understanding of normal embryonic kidney development, interested
readers are referred to recent reviews [2, 5, 6, 17].
Embryonic kidney epithelium precursor cells originate in the intermediate mesoderm
(IM) which is situated between the paraxial mesoderm and the lateral plate (see Figure 1).
From embryonic day 9.5 (E9.5), an epithelial tube forms from derivatives of a portion of the
intermediate mesoderm expressing PAX2, LHX1 and GATA3 [28]. This tube, known as the
Wolffian duct (WD), extends in a caudal direction towards the cloaca (see Figure 2a).
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Figure 1: Schematic diagram of embryo at approximately embryonic day E8 showing the location of the
intermediate mesoderm (IM). A cross-section is taken showing the location of the IM in the context of the
embryonic anatomy. The adult kidney (metanephros) will form at the caudal end near the cloaca.
Hox gene activity at approximately E10 allows for the formation of the metanephric mes-
enchyme (MM) as a derivative of the IM [23]. The MM forms at the caudal end of the WD.
Characteristic of the MM is the expression of specific transcription factors. Precisely how
these transcription factors interact to determine MM characteristics is unclear. Importantly,
specific to the MM is the expression of glial cell line-derived neurotrophic factor (GDNF)
and other growth factors.
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At approximately E10.5 the ureteric bud (UB) forms as a localised bulging and subse-
quent outgrowth of the WD; a process known as UB induction. Whilst GDNF signalling
has been shown to be critical to UB induction, outgrowth is permitted only because of
Gremlin(GREM1)-mediated inhibition of bone morphogenetic protein 4 (BMP4) which oth-
erwise blocks GDNF signalling [21].
The number and initial positioning of the ureteric bud/s along the WD, especially with
respect to the surrounding MM is critical to the subsequent branching and functionality of
the mature kidney. Loss of genes controlling single UB outgrowth can lead to duplicated
(duplex) ureters, multiplexed kidneys, and commonly, vesicoureteric reflux (VUR) [31] (see
Figures 2b and 2c). If UB induction fails, no kidney is formed (see Figure 2d). A duplicated
ureter can occur when, for various reasons, multiple UBs are induced in the WD. Duplicated
ureter is the most common type of renal abnormality, occurring in approximately 1% of the
population [30]. Whilst having multiple ureters may not be lethal, one of the ureters is often
ectopic and can increase the risk of conditions such as urinary tract infections. Displacement
of the single UB in either the cranial or caudal direction from its normal location on the
WD can lead to kidneys with dysplasia, VUR, abnormal draining through the ureter and/or
diminished functionality or capacity.
During the establishment of the UB, the cellular changes in the bud and the MM are
substantial [6]. Cells in the bud epithelium which have high expression of RET receptors (a
member of the receptor tyrosine kinase family of proteins) migrate towards the ureteric bud
tip (UT) [4]. Reciprocally, MM cells, progenitors of the nephron epithelium, condense on
the tip through an unknown mechanism and form cap mesenchyme (CM) [14]. Interactions
between CM and UB/UT cells drive the kidney development program. The CM provides UT
cells with growth factors such as GDNF and other less crucial growth factors whose precise
role is still being investigated: fibroblast growth factors (FGFs), vascular endothelial growth
factors (VEGFs), hepatocyte growth factor (HGF) and epidermal growth factor (EGF).
Autocatalysis of GDNF/RET signalling between CM and UT cells lead to the branching
of the UB after a period of outgrowth [3]. Understanding branching morphogenesis has
been the focus of a large experimental research effort. Recently, a mathematical model by
Menshykaul and Iber proposed that branching of the UB arises from the redistribution of
GDNF signalling due to a naturally-formed patterning between the rapidly diffusing GDNF
free ligand and its slowly diffusing receptor complex at the epithelium surface [19]. This
spontaneous generation of patterns in systems of interacting molecules was first explored
by the renowned British mathematician Alan Turing. In his seminal paper, he described
the possibility of diffusion-driven instabilities of an otherwise stable uniform steady state of
a chemical system leading to spatial self-organisation [32]. A particular type of simplified
reaction-diffusion system displaying similar characteristics to the model of Menshykaul and
Iber was presented in 1972 by Gierer and Meinhardt [9]. Ju¨rgen Schnakenberg [29] elaborated
on the properties of the chemical system, and therefore reaction-diffusion models of this
type are often named after him. Whilst epithelium cells are known to undergo migration
and structural changes, these changes are triggered, largely, by GDNF signalling [6]. Since
GDNF signalling appears to be the driving cause of UT cell behaviour and because there
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currently are no models to suggest otherwise, it is the opinion of the authors that the initial
cause of branching is likely due to morphogen self-organisation as proposed by Menshykau
and Iber [19].
Once the UB branches, it forms two UTs each with its own associated CM. For a review
of branching morphogenesis as well as the proceeding development of the kidney see [17].
Figure 2a is a diagrammatic summary of the stages of normal kidney morphogenesis as
described in the introduction, whilst Figures 2b-d show developmental phenotypes that have
been observed in response to genetic experimentation.
In this manuscript we investigate the GDNF signal Turing patterning mechanism, as
suggested originally by Menshykau and Iber [19] in the context of bud induction. Our
model is an extension of the partial differential equation (PDE) model of [19] to specifically
investigate the role of the known key regulators BMP and GREM1 which were previously
absent. We demonstrate how this model achieves the localisation of GDNF/RET signalling
required for a single budding site, and also how genetic modifications which disrupt this
patterning act to produce the known abnormal induction phenotypes shown in Figure 2.
We describe the role that GREM1-mediated BMP inhibition of GDNF signalling has on UB
induction according to the mathematical model. Whilst a full mathematical model including
biochemical and cellular behaviour in kidney morphogenesis has not been formalised, our
biochemical model supports the theoretical framework proposed by Menshykau and Iber [19]
and demonstrates that Turing patterning as a result of GDNF/RET feedback can explain the
behaviour of normally and abnormally developing kidneys and is controlled and stabilised
by regulating proteins such as BMP4 and GREM1.
2. Mathematical model
Normal induction of the ureteric bud (UB) from the Wolffian Duct (WD) takes place just
after E10. The important cellular populations involved in UB induction are the metanephric
mesenchymal cells (MM) and the epithelial Wollfian duct (WD) cells from which the UB
will form. The hypothesis proposed by this model is that reciprocal molecular interaction
between MM and WD is the cause for cellular change in the WD, manifesting in UB out-
growth. The molecular concentrations explicitly considered by the model are BMP4 (b),
GREM1 (m), BMP receptors (B), GDNF (g) and RET (G). Note that capitalisation of the
label for a chemical species indicates its associated receptor. The functions and interactions
of these protein species are demonstrated in Figure 3. Fibroblast growth factors, FGFs, are
thought to behave in a similar way to GDNF. Studies have shown that in Gdnf knockout ex-
periments kidney phenotypes may be recovered by knocking out Sprouty1 (Spry1 ), a known
inhibitor of RTK signaling pathways [20]; suggesting that FGFs are a weaker supplement
working in parallel with GDNF signalling (see Figure 3). For this reason, FGF signalling
is not considered explicitly in this model but can be heuristically considered to contribute
as an adjunct to GDNF/RET signalling due to their similar functionality. In their model,
Menshykau and Iber considered the well-known GDNF/WNT11 positive feedback, where
WNT11 triggers increased expression of GDNF in the mesenchyme, and WNT11 secretion is
itself upregulated by GDNF/RET signalling in the epithelial cells of the ureteric tip. We have
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not included this in our model because although WNT11 upregulation in the ureteric tip in
response to GDNF stimulation has been shown, WNT11 knockout experiments demonstrate
that even in the absence of WNT11 a ureteric bud forms normally and that it is the subse-
quent branching that is impacted [18]. Since our model describes specifically bud induction,
we require of our model that bud/s are generated without WNT11 and/or its influence on
GDNF production.
Our mathematical model contains the following parameter labelling convention. Coordi-
nate x denotes the cranial-caudal direction along the MM-WD interface, Di is the diffusion
constant of protein i, λi represents the natural cellular (MM or WD) production rate of pro-
tein i, µi is the degradation rate of protein i, ρp represents a binding rate involving protein
p and γ represents the upregulation of RET production due to GDNF/RET signalling.
2.1. Glial cell line-derived neurotrophic factor, GDNF (g)
Glial cell line-derived neurotrophic factor, GDNF, is expressed and secreted by the MM.
Extracellular GDNF diffuses and eventually binds to dimerised RET on the membrane of WD
cells, after first binding with the co-receptor GFRα1. WD epithelial cellular response to the
formation of the membrane-bound GDNF/RET/GFRα1 complex involves the activation of
key signalling pathways; ERK, MAPk, PI3K and PLCγ. It is the activation of these pathways
in the WD that causes cell proliferation and migration, along with the localised breakdown
of ECM required for epithelial outgrowth (budding). The GDNF/RET/GFRα1 complex is
thought to be endocytosed by the WD cell shortly after assembly [25], resulting in the removal
of free GDNF and RET receptors at the rate limited by this receptor complex forming
reaction. GFRα1 is here considered to act only as a regulator of GDNF/RET signalling
and thus not explicitly considered in the model. Combining the characteristic behaviours of
GDNF produces the following equation describing the evolution in its concentration g.
∂g
∂t
= Dg
∂2g
∂x2︸ ︷︷ ︸
Diffusion
+ λgχ(x)︸ ︷︷ ︸
Production
− µgg︸︷︷︸
Degradation
− ρGgG
2
︸ ︷︷ ︸
Binding with RET
. (1)
The spatial dependence of the production term indicates the spatial heterogeneity of GDNF
production along the WD, encoded by the function χ(x). The diffusion of g renders the
exact form of this function somewhat unimportant, but the chosen form must encapsulate
the increased GDNF expression in the MM at the caudal end of the WD where budding
occurs, as observed in staining experiments [16]. In more cranial regions of the MM, FOXC1
and ROBO2/SLIT2 activity suppresses GDNF expression, but the potential for abnormal
kidney morphogenesis to produce ectopic buds (e.g. [21]) implicates the presence of some
potentially-active growth factor in this region. In order to avoid further complicating the
model by explicitly modelling the complex mix of protein signals that create the spatially het-
erogeneous GDNF profile in the MM, we choose χ(x) = ([U(x)− U(x− L)]− (1− F ) [U(x)− U(x− xF
with U(x) the Heaviside step function. This function form (phenomenologically) produces
a region where GDNF is highly expressed (x = xF to x = 1), and a region along the WD
in a cranial direction where GDNF is still expressed, but only with proportion F (x = 0 to
x = XF ).
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Whilst we refer to g and G as the concentrations of GDNF and RET, respectively, the
similarities between GDNF and other growth factors (most notably FGF) suggest that the
effects of these other growth factors and their respective receptors can also be considered to
be encoded into the equations for g and G.
2.2. RET proto oncogene-encoded receptors, RET (G)
RET is a receptor tyrosine kinase (RTK) which acts specifically as the receptor for GDNF
and is expressed by the epithelial cells of the WD. Dimerised RET forms a complex with
a GDNF ligand, triggering phosphorylation of intracellular signalling proteins within WD
cells. Endocytosis removes successfully bound receptors from the system, but cells naturally
produce RET at a base rate in order to replenish them. Of particular note, RET receptors
are removed by reaction at a rate twice that of GDNF because each molecule of GDNF-RET
complex is composed of two RET receptors bound to a single GDNF ligand. RET receptors
can move across the cell’s surface, producing a (slow) diffusive effect. Importantly, activation
of signalling pathways triggered by RET phosphorylation results in an increase in the cell’s
production of further RET. Signal strength depends on the amount of both GDNF/RET
complex and BMP/BMPR complex, as discussed later in Section 2.3.
∂G
∂t
= DG
∂2G
∂x2︸ ︷︷ ︸
Diffusion
+ λG︸︷︷︸
Production
− µGG︸︷︷︸
Degradation
− 2ρGgG
2
︸ ︷︷ ︸
Binding with GDNF
+ γgG2Φ(G, g, B, b)︸ ︷︷ ︸
Upregulation due to GDNF/RET
, (2)
where gG2 is assumed to be proportional to the amount of GDNF/RET complex in pseudo-
equilibrium with the abundance of free ligand and receptor respectively and Φ(G, g, B, b)
represents the effect of the cell’s limited capacity to transduce GDNF/RET signals. This
capacity is inhibited by BMP/BMPR signalling (also discussed in Section 2.3). This model
uses a modified Michaelis-Menten form for the transduction of the GDNF/RET signal,
Φ(G, g, B, b) = 1/(1 + γgG2 + ΓBbB
2). γ and ΓB represent the respective contributions
of GDNF/RET and BMP/BMPR signalling products in restricting further GDNF/RET sig-
nal transduction downstream from the receptor level. The algebraic form of Φ(G, g, B, b)
was determined under the assumption that the intracellular response to extracellular stimuli
is fast and that the cross-talk between BMP/BMPR signalling and GDNF/RET signalling is
predominately due to competition for a common protein. Whilst the exact form of Φ might be
substantially more complicated, in the absence of more specific data this Michaelis-Menten-
like term is chosen for its relative simplicity and the known success of this type of term for
modelling signal transduction in cell biology.
2.3. Bone morphogenetic protein 4, BMP4 (b)
Bone morphogenetic protein 4, BMP4, is an extracellular signalling protein that is ex-
pressed by the mesenchyme along the entire WD [21]. BMP4 diffuses and binds to dimerised
BMPR1 receptors which, along with BMPR2 receptors, allow BMP4 to form a signalling
complex on the membrane of epithelial WD cells [8]. In a similar manner to our treatment
of GFRα1, BMPR2 receptors are not considered explicitly in the model. BMP4 signalling is
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known to inhibit the action of GDNF-RET signalling downstream of ligand binding, prevent-
ing the development of the UB(s) [21]. BMP4 is removed from the system by endocytosis
of the receptor-bound complex, but also by binding with its antagonist GREM1. Binding
with GREM1 prevents BMP from binding to its receptors and thus GREM1 indirectly en-
ables uninhibited GDNF/RET signalling and ultimately budding. Together these behaviours
produce the evolution equation for free BMP4, b,
∂b
∂t
= Db
∂2b
∂x2︸ ︷︷ ︸
Diffusion
+ λb︸︷︷︸
Production
− µbb︸︷︷︸
Degradation
− ρBbB
2
︸ ︷︷ ︸
Binding with BMPR
− ρmbm︸ ︷︷ ︸
Binding with GREM1
. (3)
2.4. Bone morphogenetic protein receptor, BMPR1 (B)
Bone morphogenetic protein receptors, BMPR1 are expressed by WD cells and may
slowly diffuse over the surface of these cells. Dimerised BMPR1 binds with BMP4 to trigger
cell signalling and later undergo endocytosis, with the cell naturally producing additional
receptors at a baseline rate to compensate. This results in the evolution equation for BMP
receptors, B,
∂B
∂t
= DB
∂2B
∂x2︸ ︷︷ ︸
Diffusion
+ λB︸︷︷︸
Production
− µBB︸︷︷︸
Degradation
− 2ρBbB
2
︸ ︷︷ ︸
Binding with BMP4
. (4)
Again, the dimerisation of BMP receptors in complex causes two to be consumed in the
process of ligand binding (and ultimately endocytosis).
2.5. Gremlin 1, GREM1 (m)
GREM1 is a diffusible antagonist of BMPs, known to have an affinity for binding to
BMP2 and BMP4 and subsequently preventing these molecules from binding with their
receptor [12].
GREM1 is secreted by the MM and has been observed to be localised to a region around
the WD budding site(s) during induction [21]. Furthermore, GREM1 continues to be lo-
calised in the CM after outgrowth and branching of the bud/s. It is widely accepted that
GREM1 locally reduces BMP4 to levels that permit GDNF/RET-derived outgrowth and
branching. The cause of GREM1 localisation remains unclear. However, GREM1 locali-
sation is strongly associated with GDNF-producing mesenchymal cells. In the absence of
plausible theoretical causal mechanisms, we explicitly prescribe a spatially dependent pro-
duction of GREM1 directly proportional to the production of GDNF, thus introducing the
same spatial dependence function χ(x) into the production term. The evolution equation
for GREM1, m, is given as
∂m
∂t
= Dm
∂2m
∂x2︸ ︷︷ ︸
Diffusion
+ λmχ(x)︸ ︷︷ ︸
Production
− µmm︸ ︷︷ ︸
Degradation
− ρmbm︸ ︷︷ ︸
Binding with BMP4
. (5)
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2.6. Non-dimensionalisation, parameters and domain
The non-dimensionalisation of Eqs (1)-(5) is performed using the following non-dimensional
variables and parameters (indicated with bar notation);
G¯
G
=
g¯
g
=
µG
λG
;
B¯
B
=
b¯
b
=
m¯
m
=
µB
λB
; x¯ =
x
L
; t¯ = t
1
µG
; (6)
D¯i =
Di
µGL2
; µ¯i =
µi
µG
; Γ¯i = Γi
λ3i
µ3i
; g¯0 =
λgµG
λGµg
; b¯0 =
λbµB
λBµb
; m¯0 =
λmµB
λBµm
; (7)
ρ¯G = ρG
λ2G
µ3G
; ρ¯B = ρB
λ2B
µ2BµG
; ρ¯m = ρm
λB
µBµG
; γ¯G = γ
λ2G
µ3G
, (8)
where the subscript i is a place holder for a chemical species; g, G, b, B or m. L is the
length of the GDNF-producing MM (usually about 500µm). Substituting non-dimensional
Eqs (6)-(8) into Eqs (1)-(5) and dropping the bar notation we arrive at our non-dimensional
model equations;
∂g
∂t
= Dg
∂2g
∂x2
+ µg
(
g0χ(x)− g
)
− ρGgG
2 (9)
∂G
∂t
= DG
∂2G
∂x2
+ µG
(
1−G
)
− 2ρGgG
2 +
γgG2
1 + ΓGgG2 + ΓBbB2
(10)
∂b
∂t
= Db
∂2b
∂x2
+ µb
(
b0 − b
)
− ρBbB
2 − ρmbm (11)
∂B
∂t
= DB
∂2B
∂x2
+ µB
(
1− B
)
− 2ρBbB
2 (12)
∂m
∂t
= Dm
∂2m
∂x2
+ µm
(
m0χ(x)−m
)
− ρmbm , (13)
where χ(x) = ([U(x) − U(x− 1)]− (1− F ) [U(x)− U(x− xF )]) is now our spatial hetero-
geneity function in terms of the non-dimensional spatial co-ordinate.
The function χ(x) is piecewise constant, and thus the model (9)-(13) can be stated more
succinctly, in any region of constant χ(x), as
∂C
∂t
= D
∂2C
∂x2
+Φ(C). (14)
Here C = (g,G, b, B,m), D is a diagonal matrix containing the respective diffusion constants
and Φ(C) is a vector-valued, non-linear function of the chemical concentrations. This form
becomes useful for the analysis that follows in Section 3.1.
The initial conditions used were chosen to represent the beginning of the induction pro-
cess, when the MM begins expressing GDNF and GREM1. Thus the initial concentrations
of these species are zero. BMP4 and the receptor species are initially set to their equilibrium
(in the absence of any interaction) concentrations,
g(x, 0) = 0; G(x, 0) = 1; b(x, 0) = b0; B(x, 0) = 1; m(x, 0) = 0. (15)
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However, we found that the steady states reached by the model were independent of the
choice of initial condition.
Table 1 lists the values that were used to numerically simulate the model in all of the
presented simulations, except where specifically outlined. Although most parameters in the
model do not have experimentally-known values, a representative choice of parameter set was
made to demonstrate the key features of the model, with choices made within experimental
ranges where physical estimates were available. The phenotypical behaviour of the model is
consistent over a wide range of parameter values. However the critical, phenotype-defining
values of the most important parameters (specifically g0 and γ) depend strongly on the
balance of the parameters b0, m0 and the relative sizes of ΓB and ΓG. Exploration of the
solution space is presented in Sections 3.1 and 3.2.
Diffusion constants (Di) of molecules can vary significantly depending on the environment
and large ranges are reported in the literature. Importantly, the diffusion rates of membrane-
bound molecular species are slower than those for free ligand species: a requirement for
Turing patterning. All free ligand and membrane-bound molecules were assumed to have
approximately the same diffusion constant respectively.
Literature reports of degradation rates (µi) can also vary by orders of magnitude. The
rates of degradation/removal of GDNF and BMPR that were chosen were within the ex-
perimentally measured range. Remaining degradation/removal rates were chosen such that
receptors were removed somewhat faster than ligands since receptors can additionally be
removed by cell regulatory processes. Internalisation of ligand/receptor complexes are often
considered much faster than free protein turnover rates. It is important to note that this is
the reason why no complex species need be explicitly considered in the model; their concen-
tration should always be in pseudo-equilibrium with the concentrations of their component
molecules.
Rates of production (λi) for proteins specific to the WD and MM are difficult to find and
were chosen rather arbitrarily. We defined a unit production rate to be that of GDNF. In this
case, specific molecular concentrations are not given quantitatively but thought of in terms
of some arbitrary units normalised to the maximum production rate of GDNF. Subsequently,
we chose BMP4 and GREM1 to have smaller production rates than GDNF and receptors to
have smaller production rates than their corresponding ligands. It is important to remember
that, after non-dimensionalisation, production rates define the equilibrium (in the absence
of multiprotein reactions) concentrations g0, b0, m0, G0, in combination with each chemical
species’ respective degradation rate.
Reaction/binding rates and other non-linear parameters (ρi, γ and Γi) were chosen specif-
ically by numerical trial and error so that the impact of each reaction considered was im-
portant to UB induction. That is, each reaction in the model had non-negligible (but also
not completely dominating) magnitudes. The reaction rates are therefore scaled against the
relative production rates of the molecular species and the effect of varying these parameters
is the focus of much of the numerical results section of this manuscript.
Spatial parameters xF and L were estimated by eye from images of GDNF-stained sections
of the IM in the literature. In the following section, we explore possible biological outcomes
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that result from significant changes in the important parameters and demonstrate that these
outcomes match those observed in a range of experiments.
2.7. Numerical Method
The non-dimensional PDEs (9)-(13) were solved using the method of lines in which all
spatial derivatives were approximated by a standard central difference approximation, to
produce a system of coupled ODEs that were then solved using MATLAB’s ode15s rou-
tine. Sufficient spatial and temporal resolution was chosen so that simulation results were
insensitive to further discretisation refinement, confirming the accuracy of the numerical
method.
There are no abrupt boundaries to the MM in the IM along the cranial-caudal axis,
and so strict boundary conditions can not simply be imposed at the edges of the ‘active’
region between x = 0 and x = 1. The use of no-flux Neumann boundary conditions at
these locations would necessarily artificially increase the concentration of critical chemical
concentrations such as GDNF. Instead, in seeking to best represent the biological situation
where there are no physical boundaries present, ‘free’ boundary conditions were used, where
GDNF and GREM1 are not actively expressed outside of the region of interest (x = 0 to
x = 1) but diffusion beyond these points may still occur. These boundaries were implemented
into the numerical solver by extending the domain substantially beyond the MM, the chosen
form of χ(x) switching off production of GDNF and GREM1 in these extended regions.
Neumann boundary conditions could then be imposed at long distances from the MM, where
the chemical concentrations of GDNF and GREM1 decay to a trivial constant value. The
extended domain is not shown in graphs because the activation of induction we are exploring
can never occur where GDNF is not present to trigger a budding response in the WD.
All simulations were run to steady state, and it was observed that almost all simulations
reached steady state within an appropriately realistic time scale for induction (less than 24
hours).
3. Numerical results and analysis
All of the numerical results presented in this section and subsections use the non-
dimensional parameters given in Table 1. Individual parameter exceptions are highlighted
in their respective subsections when parameter modifications become relevant to explore
properties of the model, or to represent gene knockout experiments.
3.1. Ligand-receptor Turing budding mechanism
It is well accepted that GDNF/RET signalling is the primary driver of the cell migratory
and proliferative behaviours that form the UB, and its subsequent extension and branching
[2]. The action of GDNF/RET signalling in producing a single localised bud is less un-
derstood. It is thought that localised expression of GREM1 (which prevents the action of
the budding inhibitor BMP4) reinforces GDNF/RET localised behaviour around the bud
site. However, GREM1-deleted mice have been shown to produce precursor buds. This
would suggest that localisation is achieved in a different manner and the purpose of localised
10
Parameter Dim. Value Value Source (units dict.) Meaning
Dg 5µm
2s−1 0.02 0.1 - 50 [13, 33] Diffusion constant (GDNF)
DG 0.01µm
2s−1 4× 10−5 10−4 - 0.5 [26, 15, 11] Diffusion constant (RET)
DB 0.01µm
2s−1 4× 10−5 t.w. Diffusion constant (BMPR)
Db 5µm
2s−1 0.02 t.w. Diffusion constant (BMP)
Dm 5µm
2s−1 0.02 t.w. Diffusion constant (GREM1)
λg (g0) 1µm
−1s−1 20 t.w. Bulk GDNF concentration
λb (b0) 0.1µm
−1s−1 20 t.w. Bulk BMP4 concentration
λm (m0) 0.1µm
−1s−1 20 t.w. Bulk GREM1 concentration
λG (G0) 0.1µm
−1s−1 1 (N/A) t.w. Base RET production
λB (B0) 0.01µm
−1s−1 1 (N/A) t.w. Base BMPR production
µg 5× 10
−4s−1 0.5 10−4 - 10−3 [13, 33] Removal of GDNF
µB 10
−3s−1 1 t.w. Removal of BMPR
µG 10
−3s−1 1 10−4 - 10−3 [13, 33] Removal of RET
µb 5× 10
−4s−1 0.5 t.w. Removal of BMP4
µm 5× 10
−4s−1 0.5 t.w. Removal of GREM1
ρG 2.5× 10
−9µm2s−1 0.025 t.w.* Binding rate (GDNF-RET)
ρB 2.5× 10
−9µm2s−1 0.00025 t.w.* Binding rate (BMP4-BMPR)
ρm 5× 10
−5µms−1 0.5 t.w.* Binding rate (BMP4-GREM1)
γ 8× 10−9µm2s−1 0.08 t.w.* Upregulation of RET
ΓG 10
−10µm3 10−4 t.w.* GDNF/RET self-inhibition
ΓB 10
−6µm3 10−3 t.w.* BMP4 inhibition of GDNF/RET
xF 0.75 0.75 ad oculos [16] Proportion of MM with reduced GDNF
(associated with ectopic budding)
F 0.1 0.1 t.w.* GDNF suppression factor
L 500µm 1 ad oculos [16] Length of MM
Table 1: Table of default parameters used in numerical tests of the mathematical model (9)-(13). The table
shows, in columns from left to right; parameter labels, the approximate values taken in this manuscript
as default parameters, the associated non-dimensional parameter, the source from which this parameter is
assumed and the meaning of the parameter with respect to the model. In the source column, units are
assumed dictum erat (dict.). See the second column for units. Where possible, source references are given
however this is often not possible and estimates are given in this work (t.w.) using physical justifications
(see text for details). Parameters marked with an asterisk (t.w.*) indicate that the parameters where chosen
such that their respective associated process was significantly affecting model outcomes but not dominating
them. This numerical approximation of parameters was performed to reflect the heuristic observations that
each of these processes are critical to successful induction of the bud. The production parameter labels which
appear in brackets are the non-dimensional equivalent labels which, instead, represent the non-dimensional
independent uniform steady states of each chemical. The final three parameters, xF , F and L, describe
the domain heterogeneity of expression of GDNF and GREM1. For a quantitatively accurate model, rather
than an phenotypical investigation which is the focus of this manuscript, many of these parameters require
experimental validation. Note that concentration is given in units per micron and binding/reaction rates are
given in units of rate of change of product concentration per second per unit concentration of each reactant.
11
GREM1 in the vicinity of the bud site is regulatory. No bud site is formed without the
action of GDNF/RET. We subscribe to theoretical hypothesis that bud site localisation is
a result of a Schnackenberg-like Turing pattern in GDNF/RET signal strength due to the
autocatalysis of RET receptors, as proposed by Menshykaul and Iber [19].
The model described in Section 2 is capable of predicting localised regions of growth
factor activation for certain sets of parameter values (for example, the diffusion of ligands
must be substantially faster than those of receptors). Critical to localised GDNF activity
is RET receptor autocatalysis. The strength of RET receptor autocatalysis is indicated by
the non-dimensional parameter γ. If γ is too strong, GDNF signalling saturates along the
WD due to uniformly high RET concentrations. We call this uniform state “saturated”.
Alternatively, if γ falls bellow a critical value, uniformly low GDNF signalling results. We
call this low RET state “inhibited”. The biological consequence of the saturated state is
interpreted as uniform WD swelling, because uniform growth signal is experienced by WD
epithelial cells. Conversely, in the inhibited state, uniformly low RET concentrations make
budding impossible, and agenesis is the associated phenotype. Under the right circumstances,
transitionally between the inhibited and saturated states, the “budding” state results from a
diffusion-driven Turing instability. We shall now define these states with more quantitative
specificity.
To find when the model undergoes a transition into a diffusion-driven instability we first
find the positive stable steady state of the well mixed chemical system (the steady state for
the model equations with no diffusion term and uniform production) 0 = Φ(Cˆ) for Cˆ > 0.
Thus the steady state concentrations for the individual non-dimensionalised chemical species,
g = gˆ, G = Gˆ, b = bˆ, B = Bˆ and m = mˆ, satisfy
0 = µg
(
g0 − gˆ
)
− ρGgˆGˆ
2 (16)
0 = µG
(
1− Gˆ
)
− 2ρGgˆGˆ
2 +
γgˆGˆ2
1 + ΓGgˆGˆ2 + ΓB bˆBˆ2
(17)
0 = µb
(
b0 − bˆ
)
− ρB bˆBˆ
2 − ρmbˆmˆ (18)
0 = µB
(
1− Bˆ
)
− 2ρB bˆBˆ
2 (19)
0 = µm
(
m0 − mˆ
)
− ρmbˆmˆ. (20)
Whilst Eqns (18)-(20) can be decoupled from the other two equations, this system of algebraic
equations does not have an analytical solution and our further analysis is performed through
numerical calculation.
Considering an initially small spatial perturbation C(x, t) = Cˆ+∆C(x, t) to the concen-
trations with a sinusoidal period of 2pi/k, the model near the uniform steady state becomes
∂ (∆C)
∂t
= J(Ψ, k) (∆C) +O(∆C2), (21)
where Ψ is some vector containing the parameters of the system (16)-(20) as well as chemical
diffusion constants Di and J(Ψ, k) is the Jacobian matrix of the vector −k
2DC+Φ(C))|
C=Cˆ.
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Thus, the uniform steady state undergoes a diffusion-driven Turing instability whenever
maxk>0 {Λmax [J(Ψ, k)]} > 0, (22)
where Λmax(·) is a function representing the largest eigenvalue of its argument. Whilst (22) is
the necessary condition for a Turing instability in the chemical system to occur, calculating
the value of the largest eigenvalue of the Jacobian contains little information about the final
Turing pattern. In the case when the Turing condition (22) is met, we can find an upper
bound on the Turing pattern’s fundamental period which importantly gives a lower bound
on the number of peaks/buds per unit (non-dimensional) length along the Wolffian duct.
This bound corresponds to the minimum value for k > 0 in which Λmax [J(Ψ, k)] becomes
positive (notice that for k → 0 the largest eigenvalue must necessarily be negative since
this corresponds to a uniform, stable, distribution). Therefore, in the regime of the Turing
instability (see condition (22)), the total number of distinct peaks/buds N per unit length
in the distribution of signal strength is bounded by N > N¯ where
2piN¯ = {k | ∀κ ∈ (0, k) : Λmax [J(Ψ, κ)] < Λmax [J(Ψ, k)] = 0} . (23)
Using all the parameters Ψ (except γ) which can be found in Table 1, we present the relative
amount of GDNF/RET signal gˆGˆ2 calculated from the numerical solution of Cˆ (described by
Eqns (16)-(20)) as a function of γ in Figure 4a. The solid line for small γ labelled inhibited
indicates that uniform solution Cˆ is stable (it does not satisfy condition (22)). It can be seen
in the figure that GDNF stimulation is relatively low in this regime. The dotted solution to
Cˆ for intermediate values of γ indicate that condition (22) is met and that a diffusion-driven
Turing pattern is made. This section is labelled budding as it corresponds to definitive peaks
in GDNF signalling. In Figure 4b we present the lower bound on the number of peaks
per unit length (a unit length corresponds to L = 500µm) in the budding state. For large
values of γ, the minimum number of peaks per unit length N¯ continues to increase until at a
large concentration of peaks, the definition between peaks is reduced due to diffusion and a
state resembling uniformly saturated signalling is approached. We have therefore defined the
‘saturated’ state arbitrarily as when the number of peaks per unit length is beyond 10. Since
the solution to the model in the saturated state is close to uniform and Cˆ, we have presented
it in Figure 4a as near stable, however the interface between budding and saturated states
is a rather gradual transition and is defined arbitrarily.
The analysis performed to define the inhibited, budding and saturated states was imple-
mented on an abstract WD with infinite length and no explicit heterogeneity. However, the
metanephros consists of a region of mesenchymal cells which produce GDNF and GREM1 at
an elevated level, with the chemical species able to diffuse beyond this region of productive
cells. In order to capture the effects of these ‘free’ boundaries, our simulations exploring
the system 9-13 still use the heterogeneous production term χ(x), except with consistent
production achieved over the region of interest by choosing F = 1. Figure 5 demonstrates
the budding state on the domain x ∈ (0, 1) with free boundaries, using the parameters in
Table 1 (except with F = 1).
Localised regions of RET-high cells are clearly seen, arising naturally from the Schnakenberg-
like kinetics of GDNF and RET receptors. The strength of active GDNF/RET signalling is
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presented in the Figure 5 with a pink line and is proportional to ∼ gG2/(1+ΓGgG
2+ΓBbB
2).
Quantitatively, the constant of proportionality depends on the rate of endocytosis and defi-
nition of signal strength and is arbitrarily scaled out of the presented results. The decreased
amount of free GDNF in the regions of high GDNF/RET signalling corresponds simply
to the increased extent of GDNF-RET binding at the interface, and does not represent a
variation in the underlying GDNF expression of the MM. Multiple peaks of GDNF/RET
signalling have been observed, however, the frequency of these peaks may not be regular as
the boundary conditions introduce heterogeneity into the system, specifically in GDNF and
GREM1 (and therefore, indirectly, BMP4). A single, localised bud requires the budding state
to be active, with the additional budding peaks suppressed by FOXC and ROBO2/SLIT2
activity. Figures 6(a) and 6(b) demonstrate the effects of substantially decreasing and in-
creasing RET autocatalysis (γ = 0.05 and γ = 0.2, respectively). These figures are typical
of the inhibited and saturated states, respectively, as we have previously discussed. Notice,
however, that near the boundaries of the saturated state, GDNF and GREM1 levels decay
to concentrations which allow for more well-defined peaks normally associated with budding.
To the authors’ best knowledge, this effect has not been observed experimentally.
3.2. The Role of BMP4 and GREM1
Whilst the budding behaviour of the WD most critically depends on the extent of RET
upregulation in response to GDNF, γ, the budding window is controlled by the concentration
of GDNF (from g0) and the regulatory GREM1/BMP4 system. Figure 7a shows how the
values of the RET upregulation rate γ and the GDNF signal strength g0 determine the
essential behaviour of the model in the absence of GREM1 (m0 = 0). The default parameters
which have been used in Figures 5 and 6 are indicated explicitly in Figure 7. Figures 7b and 7c
show, in red, the effect of increasing cellular response to BMP, and actual BMP concentration
respectively on the budding behaviour of the system compared to the behaviour shown in 7a.
Figures 7d, 7e and 7f show, in blue, the effect of adding in GREM1 in quantities described
by Table 1 to the systems described by Figures 7a, 7b and 7c respectively.
It is clear from the model and from Figures 7b and 7c that BMP4 can be a potent
inhibitor of potential budding (requiring more GDNF and RET upregulation to produce
buds). Introducing GREM1 into the model (setting m0 to its value in Table 1) can easily
recover budding behaviour in the case of increased BMP4 sensitivity but struggles to correct
for large BMP4 concentrations. This indicates a role for GREM1 in making the WD budding
more robust to fluctuations in BMP4 signal sensitivity. On the other hand, GREM1 does
not prevent BMP4 in increased doses from inhibiting the budding of the WD. This is likely
due to the mechanism by which GREM1 inhibits BMP4 (direct 1-to-1 binding). This is
important since BMP4 inhibition of ectopic buds is crucial to a healthy kidney with a single
ureter. One point that is important to make is that, whilst it appears that the addition of
GREM1 does not effect the system behaviour by itself (see Figures 7a compared with 7d),
the frequency of the buds (indicated by shading) is affected. When we later use realistic
geometry which includes suppression of GDNF to one budding site, we see that ablation of
GREM1 results in no buds due to this change in budding frequency.
14
3.3. UB Induction in the Developing Kidney
In the developing kidney, strong GDNF expression is limited to a small region of the MM,
towards the caudal end of the WD. However, away from this region GDNF is still expressed
by the MM but in a reduced amount due to the presence of inhibitory factors like FOXC1/2
and ROBO2/SLIT2 signalling. Additionally, other growth factors which are known to be
capable of triggering budding under certain conditions (most likely FGFs) are also expressed
by the MM. Regional GDNF production is indicated in the model by g0, the uninhibited
natural GDNF concentration in the GDNF ‘active’ region, and Fg0 (0 < F < 1) in the
‘suppressed’ region. The non-dimensional position xF indicates the location along the MM
whereby GDNF suppression stops and the active region begins. In all of the figures which
are to follow, the region of GDNF and GREM1 expression is bounded by the two vertical
black lines, the divide between the suppressed expression and the most active expression is
given by the black dashed line and labelled accordingly.
The following simulations use the values provided in Table 1 unless otherwise stated
for the particular genetic condition. All figures in this section have been plotted using
dimensionalised spatial coordinates x to better visualise the spatial scale of the signalling
profile.
3.3.1. The wild-type kidney
In the wild type kidney, a single spike of growth factor activation triggers the induction
of the ureteric bud in the GDNF-active region of the MM. The model’s simulation of this
scenario is demonstrated in Figure 8, where it can be seen that GDNF/RET signalling nearly
vanishes outside of the peak of activation due to the much lower GDNF concentrations away
from this region. A natural question at this point is: How necessary is the Turing pat-
terning for localisation of GDNF/RET signalling when the concentration profile for GDNF
already demonstrates a high degree of localisation in the GDNF active region at the time
of induction? This question is addressed by considering how kidney induction, alongside
the mathematical model, respond when the GDNF profile is changed. More specifically, if
a single localised bud was achieved solely by the heterogeneity of the GDNF profile, then
increasing the width of the GDNF-active region should simply produce a wider peak of ac-
tivation (corresponding to hydroureter). Instead, experiments (and our model) demonstrate
multiple peaks of activation as discussed in Section 3.3.2.
Be aware that, when interpreting the profiles of free molecules (such as GDNF) in Figure
8 as well as subsequent figures these concentrations represent those in a thin boundary
layer near the MM/WD interface and is not indicative of the bulk concentrations which are
observed in experiments. For this reason, it is difficult to compare free protein concentrations
with experiments except indirectly through their effects on signalling (the pink curve in the
figures).
3.3.2. Foxc2−/− or Robo2−/−/Slit2−/− kidneys
When Foxc, Robo2 or Slit2 genes are deleted, the GDNF-active region is expanded [10,
16], corresponding in our model to a decrease in xF . A properly predictive model for how
the presence/absence of these genes affects the spatial profile of GDNF requires a more
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detailed and quantitative understanding of the transcriptional activity of the MM and has
not yet been attempted in the literature. The effect of this modified GDNF profile on kidney
morphogenesis is pronounced, with these genotypes producing duplex ureter or occasionally
renal hypodysplastic phenotypes [10, 16].
By decreasing xF , the proportion of the domain that is exposed to high GDNF expres-
sion, and thus in the ‘budding’ regime, is increased, allowing for multiple distinct peaks of
GDNF/RET signalling to form. Following experiments which stained for GDNF in Foxc-
disrupted mice with congenital hydrocephalus and revealed an approximate doubling of the
region of high GDNF expression [16], we doubled the width of this region in the model by
choosing xF = 0.5 and simulated the model again with all other parameters unchanged.
As expected, when the fundamental properties of the Turing pattern (peak height, peri-
odicity) are essentially unchanged, a doubling of the Turing-active region simply produces
twice as many peaks of equivalent shape, namely two (Figure 9). This result of two equal
peaks of strong GDNF/RET activation corresponds to the formation of two viable ureters,
in concordance with the duplex ureter kidneys that are produced in Foxc1 -disrupted mice.
3.3.3. Spry1−/− kidneys or kidneys experiencing exogeneous GDNF
In the case where GDNF/RET signalling is increased, the typical UB which forms in the
GDNF active region is much thicker than it should be (and goes on to develop abnormally)
and a large number of additional ectopic buds form along the WD [1]. This can be achieved
for example by genetic knockout of the inhibitor SPRY1 or by external supply of additional
recombinant GDNF [1]. In the mathematical model, which does not explicitly consider
the mechanism by which SPRY1 limits growth factor signalling, a Spry−/− environment is
replicated by increasing the strength of the behaviours triggered by growth factor signalling.
That is, RET autocatalysis (γ) is increased. The case of an exogeneous supply of additional
GDNF could be heuristically replicated in the model simply by increasing g0 (however, this
simply gives the same model predictions as the case of increased γ and so is not shown
explicitly).
In both cases the induction profile predicted by the model matches that of experiments,
as demonstrated in Figure 10. As can be seen in Figure 7, increasing the extent of growth
factor activation by changing either γ or g0 can potentially cause previously Turing-enabled
regions of the domain to enter the saturated state, while previously inhibited regions can
enter the budding regime. The budding behaviour observed cranially along the WD in these
experiments is difficult to explain in the absence of Turing patterning, which validates the
model and provides strong suggestion that a Schnakenberg-like or other pattern formation
effect derived directly from GDNF/RET signalling indeed governs kidney induction in the
developing embryo.
3.3.4. Spry1−/− and Gdnf−/− kidneys
It has been hypothesised that FGFs may play a similar role to GDNF in kidney mor-
phogenesis, albeit to a much less significant extent. The strongest evidence for a sort of
equivalence between GDNF and FGFs comes from the experiments demonstrating that in
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GDNF-null kidneys (which typically do not form at all, i.e. renal agenesis), further knock-
out of SPRY1 and hence increasing the sensitivity of WD epithelial cells to growth factors
recovers a single bud phenotype [20]. However if FGF10 is also removed by genetic deletion,
the phenotype returns to agenesis, demonstrating the potential for FGF10 at least to act
as a substitute for GDNF. Thus to a certain extent we can consider the effects of FGF in
our model by simply including it as a contributory component of our chemical species g,
which can then be thought of simply as growth factor. To simulate GDNF ablation and
only include the effects of FGF, g0 is reduced to 30% of its original value, with γ now rep-
resenting the upregulation of FGFR in response to FGF/FGFR signalling. Given that the
Turing patterning argued here as responsible for bud formation requires some sort of auto-
catalysis (γ > 0), this implies that FGF/FGFR signalling must also auto-upregulate. Such
auto-upregulation has not been reported in the kidney, presumably because the substantial
positive feedback in GDNF/RET signalling (in the form of RET upregulation) is far more
important and well-established. In a Spry1−/− genotype, however, downstream signalling
effects are significantly increased and this could strengthen the weaker baseline autocatalysis
of FGF/FGFR signalling to a level significant enough to enter the Turing regime.
Setting γ = 0.16, a value significantly less than that used for GDNF/RET feedback in a
Spry1−/− genotype, the budding state is indeed achieved in the active region and a single bud
of induction is recovered (see Figure 11). Whilst the signal strength appears to be smaller
than that in Figure 8, the effectiveness of this signal is increased due to the ablation of
SPRY1. How budding in this situation may occur can be explained using Figure 7a (moving
the red dot reference down and to the right, whilst remaining in the budding state). It
should be reiterated, however, that this does require that FGF/FGFR signalling upregulates
the production of FGFR in order to produce any kind of autocatalytic effect (even if this
upregulation is significantly weaker than RET upregulation in response to GDNF/RET
signalling). This property of FGFR is yet to have been reported in Spry1−/− experiments.
3.3.5. Grem1−/− kidneys and Grem1−/−/Bmp4+/− kidneys
Grem1 deletion has not been shown to prevent precursory induction. However, the
ureteric bud (which forms in the correct place) does not exhibit any significant outgrowth
[21]. The same work showed that when BMP4 is partially knocked out via single allele
deletion, Grem1 knockout kidneys regain normal development, strongly suggesting that one
of the roles of GREM1 is reducing BMP4 levels via its direct antagonism. These behaviours
are also predicted by the mathematical model. When a Grem1 deletion is represented in the
model by setting m0 to zero, BMP4 inhibition is strong enough to transition the number of
buds in the GDNF active region from one to zero. That being said however, a small amount
of localised signal is seen at the budding site due to the larger concentration of GDNF in
this region (Figure 12). This small peak in signal may be substantial enough to drive local
WD swelling, but not enough to continue outgrowth which is halted in Grem1 knockout
experiments.
When BMP4 levels are reduced by single allele deletion alongside Grem1 deletion (rep-
resented in the model by halving the value of b0 whilst holding m0 = 0), normal budding is
restored (Figure 13), matching experimental observations.
17
4. Discussion and Conclusions
In this paper we have presented a mathematical model for the induction of the ureteric
bud in the developing kidney. Localisation of this bud has generally been attributed to the
restriction of strong GDNF signalling to a small region towards the caudal end of the Wolffian
duct, and the presence of GREM1 in this region reducing the extent to which BMP4 is able
to inhibit budding. Here, the suggestion of Menshykau and Iber that kidney budding could
instead arise due to the self-organisation of morphogenic signals according to Schnakenberg-
like Turing kinetics [19] has been considered in more detail, including the effects of other key
signalling proteins in the induction process (BMP4, GREM1, FGFs). This extended model
has successfully demonstrated how the hypothesis that Turing patterning drives ureteric bud
induction is able to naturally predict a range of aberrant induction phenotypes which occur
in response to various gene deletions. This is critical because it clearly demonstrates that
GDNF localisation alone cannot predict the range of kidney phenotypes that are seen in
abnormal mice.
BMP4 is responsible for blocking the formation of ectopic buds. A single bud requires the
action of GREM1. The role of the localised GREM1 in the model is multifaceted. Whilst it
is known that GREM1 localisation around the ureteric bud increases GDNF/RET signalling
and subsequently bud outgrowth and branching, the presented mathematical model unintu-
itively predicts that GREM1 upregulation also plays a role in regulating BMP4 sensitivity
but not the response to increased BMP4 doses.
In the absence of GDNF signalling, growth factors such as FGF10 and others are sufficient
to induce a ureteric bud so long as downstream antagonist SPRY1 is also deleted [20]. The
mathematical model predicted that this is possible, but only if autocatalysis of growth factor
receptors in response to growth factor signalling exists (however, this autocatalysis is likely to
be significantly weaker than the well documented upregulation of RET receptors in response
to GDNF/RET signalling).
It should be pointed out that the model presented here is not complete. Indeed crucial
genes such as the Wilm’s tumour suppressor-1 gene (WT1 ) are thought to interact with early
kidney GDNF signalling [7] but just how this is accomplished is unclear and is not considered
in the model. Furthermore, GREM1 and GDNF share upstream transcriptional cross-talk.
How this cross-talk affects the co-expression of GREM1 and GDNF remains uncertain as
well as its possible implications for kidney induction and morphogenesis.
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Figure 2: The normal and aberrant developmental process of the metanephros from embryonic day E8
until embryonic day E16. a) Normal development: The Wolffian Duct (WD) forms from the Intermediate
Mesoderm (IM) from E8 until E9.5. Derived from the IM, by E10, the Metanephric Mesenchyme (MM) cell
population is established at the caudal end of the WD. Reciprocal stimulatory signals between the MM and
WD stimulate the outgrowth of the Ureteric Bud (UB) into the MM as well as the condensation of MM
cells to the Ureteric bud Tip (UT) (forming the Cap Mesenchyme (CM)) at about E10.5. Bifurcation of
the initial UB occurs at about E11.5. Further generations of branches will eventually form the collecting
duct system of the kidney whilst the UB will form the mature ureter. b) FOXC1 and ROBO2/SLIT2
signalling are responsible for limiting the cranial extension of the MM population. In the absence of any of
these proteins, multiple UBs can form leading to abnormalities such as a duplex ureter. c) SPRY1 acts as
an antagonist downstream of GDNF/RET signalling between MM and WD. Spry1 knockout experiments
result in WD swelling at the location of the MM whilst ectopic buds form along the WD away from the MM.
These experiments do not yield functional kidney phenotypes. d) Knockout experiments of Gdnf, Ret and
others do not allow for the signals necessary for budding between MM and the WD to occur. The result
is renal agenesis. Importantly, whilst a precursory bud site is established, agenesis occurs when Gremlin1
(GREM1), a BMP antagonist, is removed; indicating that GREM1 is crucial to the induction of a UB.
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Figure 3: The signalling proteins and receptors considered by the model, and their interactions. Cellular
behaviour required of epithelial cells to form a bud is achieved largely by GDNF/RET with adjunctive
FGF/FGFR signalling. Most importantly, GDNF/RET signalling triggers upregulation of receptors. SPRY1
has been identified as a key suppressor of the signalling pathways activated by GDNF/RET. BMP inhibits the
same signalling pathways downstream of their receptors. GREM1 is expressed by MM cells and antagonises
extracellular BMP4. Experiments have shown that GREM1 and GDNF expression have correlated spatial
profiles. The nature of this correlation remains unclear and is implemented in the model explicitly.
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Figure 4: Typical GDNF/RET signalling predicted by the non-dimensional model (9)-(13) on an infinite
domain using parameters in Table 1 as a function of the critical strength of RET positive feedback upregula-
tion derived from GDNF/RET signalling (γ). Figure a) is a plot of the uniform steady relative GDNF/RET
receptor complex concentration gˆGˆ2 defined by the well-mixed system Cˆ (Eqns (16)-(20)) as a function of
RET feedback γ. The labelled inhibited state describes the regime when the uniform steady state is stable
in the presence of diffusion in the model (condition (22) is not met). Figure b) is a plot of the minimum
number of GDNF/RET peaks (buds) N¯ per unit length that results when the condition (22) for a Turing
instability is met. This bound is found by Eq (23). Once the number of buds per unit length exceeds 10,
we consider the GDNF/RET signal to be uniformly saturated as the steady state Turing peaks merge. This
state is labelled as the saturated state and is near the uniform steady state. The dotted and solid parts
of the line in Figure a) therefore indicate when the uniform steady state is unstable or near stable under
diffusion respectively.
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Figure 5: The budding state: the Schnakenberg-like Turing pattern that appears as the steady state of
the mathematical model (9)-(13). The model is simulated with the parameters listed in Table 1 with the
modification that F = 1. Clear peaks of GDNF/RET signalling complex are seen (pink curve). The extent
of GDNF/RET signalling is defined proportional to ∼ gG2/(1 + ΓGgG
2 + ΓBbB
2) and scaled suitably to
the y-axis. It is postulated that UB localisation in the developing kidney is due to preferential growth and
migration in the regions of high GDNF/RET signal. The receptor species G and B are not visualised except
indirectly in their contribution to GDNF/RET signal strength.
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Figure 6: Steady state of the mathematical model (9)-(13). The model is simulated with the parameters
listed in Table 1 with the modification that F = 1 and (a) γ = 0.05 and (b) γ = 0.2. The extent of
GDNF/RET signalling (shown in pink) is defined proportional to ∼ gG2/(1 + ΓGgG
2 + ΓBbB
2) and scaled
suitably to the y-axis. These chemical profiles are typical of the (a) inhibited and (b) saturated states
respectively. Lines which are barely visible all lie close to 0.
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Figure 7: Diagram of the g0-γ parameter space showing regions in which the three phenotype states are
observed: inhibited, saturated and budding. Figure (a) shows the state space in which all parameters (aside
from m0 = 0 and those being varied in the graph) are identical to those used in Figure 5. The parameters
g0 and γ used in Figure 5 are indicated with a red dot and those of Figures 6a and 6b with a respective
black and blue dot for reference purposes. The shading of the budding state indicates the number of peaks
that are observed over the length of the MM, indicated by the colorbar. The state space of Figure (a) is
shown in black in all of the figures as a reference for comparison. Figures (b) and (c) show the inhibitory
effect of BMP4 on the state space by significantly increasing BMP4 sensitivity by a factor of 50 (Figure
(b)) and significantly increasing BMP4 concentration by a factor of 50 (Figure (c)). In both cases, the
parameters associated with the red dot now lie within the Inhibited state and subsequently no buds are
formed. Figures (d), (e) and (f) show the effect of introducing GREM1 m0 into the model according to the
value in Table 1 using the parameters from Figures (a) (b) and (c) respectively. GREM1 upregulation does
not significantly affect the state space if BMP4 inhibition is low (Figure (d)) but may alter the distance
between buds (potentially allowing the number of buds to go from one to zero when the domain is restricted
to the caudal end of the MM). However, GREM1 appears to be effective in the stabilisation of the budding
state against significant changes to BMP4 sensitivity (Figure (e)) whilst still allowing the WD to remain
responsive to increases in inhibitory BMP4 concentration itself which is crucial in the prevention of ectopic
budding (Figure (f)).
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Figure 8: GDNF/RET localisation leading to a single UB towards the caudal end of the MM in the wild
type kidney. Parameters used are those presented in Table 1. The GDNF producing MM is bounded by the
solid black lines and the regions of active and suppressed GDNF production separated by a dotted black
line at the non-dimensional location xF (which is manually introduced to match the spatial extent of active
GDNF expression observed in experiments). GDNF, BMP, GREM1 and GDNF/RET signal strength are
indicated using red, blue, green and thick pink lines respectively.
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Figure 9: GDNF/RET localisation at two locations leading to the induction of multiple ureters in a
Foxc1 ch/ch or Robo2−/−/Slit2−/− kidney due to the increased width of the GDNF active region. Pa-
rameters used are those presented in Table 1, except for xF = 0.5. The GDNF producing MM is bounded
by the solid black lines and the regions of active and suppressed GDNF production separated by a dotted
black line. GDNF, BMP, GREM1 and GDNF/RET signal strength are indicated using red, blue, green and
thick pink lines respectively.
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Figure 10: Hyrdoureter and multiple ectopic budding phenotype resulting from increased GDNF/RET sen-
sitivity (for example in Spry1−/− knockout experiments). In accordance with experimental observation, the
main UB that forms in the active GDNF region is much wider, due to transition into the saturation state.
The higher degree of stimulation allows a smaller amount of GDNF to transition the GDNF suppressed
region from the inhibited state into the budding state, inducing a number of additional buds along the WD.
Parameters used are those presented in Table 1, but with γ = 0.48, six times its original value. The GDNF
producing MM is bounded by the solid black lines and the regions of active and suppressed GDNF production
separated by a dotted black line and positioned at the non-dimensional position xF . GDNF, BMP, GREM1
and GDNF/RET signal strength are indicated using red, blue, green and thick pink lines respectively.
30
Position along WD (µm)
-100 0 100 200 300 400 500 600
D
im
en
si
on
le
ss
 C
on
ce
nt
ra
tio
n
0
5
10
15
20
25
30
GDNF
BMP4
GREM1
GDNF/RET signal strength
Active
FGF Suppressed
FGF
Figure 11: FGF recovery of a single bud in accordance with Spry1−/− and Gdnf −/− experiments. According
to the model, FGF/FGFR derived upregulation of FGFR must be present, even if it is weaker than the
equivalent process for RET. Parameters used are those presented in Table 1, but with γ = 0.16, only twice
its original value, as well as g0 = 6. The GDNF producing MM is bounded by the solid black lines and the
regions of active and suppressed GDNF production separated by a dotted black line and positioned at the
non-dimensional position xF . GDNF, BMP, GREM1 and GDNF/RET signal strength are indicated using
red, blue, green and thick pink lines respectively.
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Figure 12: Model output demonstrating the effects of deleting Grem1. Without GREM1 antagonism of
BMP4, growth factor signalling is inhibited enough to modify the Turing pattern such that the region of
high GDNF activity is no longer wide enough to establish a peak of activation. A small peak still forms, due
to the heterogeneous expression of GDNF in the MM. This is representative of kidney behaviour in Grem1
deletion experiments where slight swelling is seen at the caudal end of the WD, but an outgrowing bud fails
to form. Parameters used are those presented in Table 1, but with m0 = 0. The GDNF producing MM
is bounded by the solid black lines and the regions of active and suppressed GDNF production separated
by a dotted black line and positioned at the non-dimensional position xF . GDNF, BMP, GREM1 and
GDNF/RET signal strength are indicated using red, blue, green and thick pink lines respectively.
32
Position along WD (µm)
-100 0 100 200 300 400 500 600
D
im
en
si
on
le
ss
 C
on
ce
nt
ra
tio
n
0
5
10
15
GDNF
BMP4
GREM1
GDNF/RET signal strength
GDNF
Active
GDNF Suppressed
Figure 13: Model output demonstrating restoration of a single bud phenotype by the deletion of one Bmp4
allele in a GREM1-deficient kidney. Parameters used are those presented in Table 1, except with m0 = γm =
0 and b0 = 10, half its original value. The GDNF producing MM is bounded by the solid black lines and the
regions of active and suppressed GDNF production separated by a dotted black line and positioned at the
non-dimensional position xF . GDNF, BMP, GREM1 and GDNF/RET signal strength are indicated using
red, blue, green and thick pink lines respectively.
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